Financhill
Back

ADMA Biologics Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
60

ADMA
ADMA Biologics

Last Price:
$17.44
Seasonality Move:
2.93%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
$118.99
Seasonality Move:
12.18%
Buy
60
ADMA Biologics (ADMA) is a Buy

Is ADMA Biologics a Buy, Sell or Hold?

  • The current ADMA Biologics [ADMA] share price is $17.40. The Score for ADMA is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ADMA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $118.97. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ADMA Stock Price Chart

What is ADMA Biologics's stock price today?

  • The ADMA Biologics share price today is $17.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADMA is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $118.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

ADMA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.49 Sell
Relative Strength Index (14 RSI): 36.96 Sell
Chaikin Money Flow: -1885228 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.47 - 20.95) Sell
Bollinger Bands (100): (15.72 - 20.54) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 43.28 Sell
Chaikin Money Flow: -1117882 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (112.92 - 130.54) Sell
Bollinger Bands (100): (118.37 - 135.77) Sell

ADMA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.44 Sell
20-day SMA: 19.54 Sell
50-day SMA: 18.85 Sell
200-day SMA: 13.53 Buy
8-day EMA: 18.31 Sell
20-day EMA: 19.03 Sell
50-day EMA: 18.96 Sell
200-day EMA: 14.51 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 123.1 Sell
20-day SMA: 125.31 Sell
50-day SMA: 122.99 Sell
200-day SMA: 129.64 Sell
8-day EMA: 122.43 Sell
20-day EMA: 123.17 Sell
50-day EMA: 123.7 Sell
200-day EMA: 126 Sell

ADMA Biologics Earnings Growth & ADMA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.17 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.75 per share, and an increase next year of $7.84 per share.

ADMA Biologics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):